Dow (DOW) Q4 2025 earnings review
The Kitchen Sink Quarter: Massive Impairments and Thin Profits
Dow closed 2025 with a brutal quarter, reporting a GAAP Net Loss of $1.5 billion driven by over $1 billion in impairment charges. Even stripping away these one-time items, the operational picture is bleak: Operating EBIT collapsed to just $33 million (down 93% YoY), barely staying positive. Revenue fell 9% YoY as the company faces an 'unprecedented industry downturn.' Management's response is the new 'Transform to Outperform' strategy, promising $2 billion in earnings uplift, but the financials show a company struggling to cover its dividend with organic cash flow.
🐂 Bull Case
The company achieved over half of its $6.5B near-term cash/cost support actions. The new 'Transform to Outperform' plan targets an additional $2B in near-term earnings through radical simplification.
Performance Materials & Coatings was the only segment to grow Operating EBIT YoY (+$34M), driven by lower fixed costs, proving some parts of the portfolio can weather the storm.
🐻 Bear Case
Industrial Intermediates & Infrastructure (II&I) swung from an $84M profit a year ago to a massive $201M loss this quarter, dragged down by lower integrated margins and weak demand.
Operating Cash Flow ($298M) failed to cover Capital Expenditures ($568M), resulting in negative Free Cash Flow of -$270M. The dividend ($251M) was funded effectively by balance sheet cash, not Q4 earnings.
⚖️ Verdict: 🔴🔴
Bearish. While the 'kitchen sink' impairments clean up the balance sheet, the underlying operations are barely profitable ($33M EBIT on $9.5B Sales). Negative free cash flow and a collapsing Industrial segment overshadow the cost-cutting narrative.
Key Themes
Asset Value Capitulation
Dow acknowledged that certain assets are structurally impaired, taking a $690 million goodwill charge in Polyurethanes & Construction Chemicals and a $303 million charge for Latin American assets. This 'kitchen sink' accounting signals that management sees 'lower for longer' converting into 'lower forever' for these specific businesses.
Industrial Intermediates Profit Collapse
Reversing. The II&I segment has turned into a major drag on the company. Operating EBIT fell to negative $201 million from a profit of $84 million last year. Management cited lower integrated margins for MEG (Kuwait JVs) and declining local prices. This segment is currently bleeding cash and erasing gains from other divisions.
Transform to Outperform Strategy
Accelerating. With organic growth stalled, Dow is doubling down on cost outs. The new strategy aims for $2 billion in near-term earnings improvements via 'radical simplification.' In 2025, they delivered $400M in savings from the prior $1B program. The reliance on cost cutting to drive EPS is increasing as top-line levers fail.
Volume and Price Deflation
Decelerating. Net sales fell 9% YoY. Local price dropped 8%, and Volume fell 2%. The volume decline was led by Packaging & Specialty Plastics (-2%) due to the idling of a cracker in EMEAI. The lack of pricing power (-8%) in an inflationary cost environment is crushing margins.
Cash Flow Under Pressure
Reversing. Cash provided by operating activities fell to $298M (down $513M YoY). This drop was driven by lower earnings. With CapEx at $568M, Free Cash Flow was negative $270M. While the company has cash on hand ($3.8B), burning cash in Q4 is a deterioration from the $44M positive FCF in 24Q4.
Other KPIs
Missed positive territory completely. Compare this to $0.00 in 24Q4 and $-0.19 in 25Q3. The trend is worsening, not improving, despite the cost-saving measures.
Decelerating. Calculated as $215M EBIT on $4,744M Sales. This compares to 8.4% in 24Q4 ($447M/$5,315M). Margin compression continues due to lower downstream polymer prices.
Stable. Total debt (Short + Long term) is ~$18.1B, up from ~$16.3B a year ago. With EBITDA under pressure, leverage ratios are deteriorating naturally.
Guidance
Management expects 'Transform to Outperform' efforts to provide at least $2 billion in additional near-term earnings. This is a strategic target rather than quarterly guidance, reflecting the lack of visibility in the macro environment.
Reported actual. Down 7% from $42.96B in 2024. This sets a lower base for 2026 growth expectations.
Key Questions
Dividend Sustainability
With Free Cash Flow turning negative in Q4 (-$270M) and Operating EBIT ($33M) significantly below the quarterly dividend payment (~$250M), how long can the current payout be maintained without a recovery in the macro environment?
II&I Segment Turnaround
The Industrial Intermediates segment swung to a $201M loss. Is this the bottom, or do the structural issues with MEG margins and Kuwait JVs persist into 2026? What specific actions are being taken to stop the bleeding in this segment?
Impairment Signals
The $690M goodwill impairment in Polyurethanes suggests a permanent reduction in earnings power. Does this trigger a potential divestiture of these assets under the 'Transform to Outperform' strategy?
Cost Savings vs. Inflation
You achieved $400M in savings this year, yet Operating EBIT barely stayed positive. Are cost savings simply offsetting inflation and fixed cost absorption issues, or will we see true margin expansion in Q1 2026?